SCHEMBL6651818

SCHEMBL6651818

C#Cc1ccc2c(c1)CC(=O)CC2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.48
TYMS P04818 1/20 0.40
CYP1A2 P05177 3/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP11B1 P15538 2/20 0.36
CYP11B2 P19099 2/20 0.36
CYP2C19 P33261 2/20 0.36
AKR1C3 P42330 1/20 0.35
SLC6A4 P31645 1/20 0.33
GRM5 P41594 1/20 0.33
PNMT P11086 1/20 0.33
DRD2 P14416 1/20 0.33
DRD3 P35462 1/20 0.33
GABRA1 P14867 1/20 0.31
GABRG2 P18507 1/20 0.31
GABRB3 P28472 1/20 0.31
GABRA5 P31644 1/20 0.31
GABRA3 P34903 1/20 0.31
GABRA2 P47869 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9014737 0.82 TYMS (0.40) TYMSAKR1C3SLC6A4GRM5PNMT
SCHEMBL30748420 0.81 PNMT (0.51) CYP2A6CYP1A2CYP3A4CYP2C9CYP11B1
SCHEMBL2728148 0.81 PNMT (0.51) CYP2A6CYP1A2CYP3A4CYP2C9CYP11B1
SCHEMBL30018898 0.74 DRD2 (0.51) CYP2A6CYP1A2CYP3A4CYP2C9CYP11B1
SCHEMBL2086321 0.74 DRD2 (0.51) CYP2A6CYP1A2CYP3A4CYP2C9CYP11B1
SCHEMBL8669783 0.74 TSHR (0.40) TYMSCYP11B1CYP11B2AKR1C3SLC6A4
SCHEMBL9432052 0.74 ALDH1A1 (0.41) TYMSAKR1C3SLC6A4GRM5PNMT
SCHEMBL5547927 0.72 CYP2A6 (0.56) CYP2A6CYP1A2CYP3A4CYP2C9CYP11B1
SCHEMBL6979260 0.72 GRM5 (0.62) TYMSCYP1A2CYP11B1CYP11B2GRM5
SCHEMBL571181 0.71 RAB9A (0.38) TYMSCYP1A2CYP3A4SLC6A4GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6762188-B1 INHIBITING THYMIDYLATE SYNTHASE; COLON, BREAST OR LUNG CARCINOMA SMITHKLINE BEECHAM CORPORATION 2004-07-13 US disclosed
EP-1199307-B1 Pharmaceutically active benzoquinazoline compounds WELLCOME FOUND (GB) 2004-02-25 EP disclosed
EP-1199307-A1 Pharmaceutically active benzoquinazoline compounds THE WELLCOME FOUNDATION LIMITED (GB) 2002-04-24 EP disclosed
US-6306865-B1 SYNTHASE INHIBITORS AND ANTITUMOR AGENTS GLAXO WELLCOME INC. 2001-10-23 US disclosed
US-6090941-A Pharmaceutically active benzoquinazoline compounds GLAXO WELLCOME INC. (US) 2000-07-18 US disclosed
CN-1049215-C Process for preparing benzoquinazoline thymidylate synthase inhibitors WELLOCOME FOUNDATION LTD (GB) 2000-02-09 CN disclosed
US-5663337-A ENZYME, ANTITUMOR GLAXO WELLCOME INC. (US) 1997-09-02 US disclosed
US-5661155-A THYMIDYLATE SYNTHASE INHIBITOR; ADMINISTERING TO THE MAMMAL SUFFERING FROM LEUKEMIA OR TUMOR 2-(5-(((1,2-DIHYDRO-3-METHYL-1-OXOBENZO(F)QUINAZOLINE-9-YL) METHYL)AMINO)-1-OXO-2-ISOINDOLINYL)GLUTARIC ACID OR SALTS GLAXO WELLCOME INC. (US) 1997-08-26 US disclosed
US-5405851-A Administering benzoquinazoline thymidylate synthase inhibitors BURROUGHS WELLCOME CO. (US) 1995-04-11 US disclosed
EP-0535034-A1 PHARMACEUTICALLY ACTIVE BENZOQUINAZOLINE COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1993-04-07 EP disclosed
CN-1058208-A PHARMACEUTICAL COMPOUNDS WELLCOME FOUND (GB) 1992-01-29 CN disclosed
WO-1991019700-A1 PHARMACEUTICALLY ACTIVE BENZOQUINAZOLINE COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1991-12-26 WO disclosed